Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Army
Moodys
Federal Trade Commission
Fuji
Teva
Johnson and Johnson
Fish and Richardson
Cipla

Generated: April 19, 2018

DrugPatentWatch Database Preview

ZORBTIVE Drug Profile

« Back to Dashboard

Which patents cover Zorbtive, and what generic alternatives are available?

Zorbtive is a drug marketed by Emd Serono and is included in one NDA.

The generic ingredient in ZORBTIVE is somatropin recombinant. There are four drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the somatropin recombinant profile page.

US Patents and Regulatory Information for ZORBTIVE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emd Serono ZORBTIVE somatropin recombinant INJECTABLE;INJECTION 021597-001 Dec 1, 2003 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Emd Serono ZORBTIVE somatropin recombinant INJECTABLE;INJECTION 021597-004 Dec 1, 2003 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Emd Serono ZORBTIVE somatropin recombinant INJECTABLE;INJECTION 021597-002 Dec 1, 2003 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Emd Serono ZORBTIVE somatropin recombinant INJECTABLE;INJECTION 021597-003 Dec 1, 2003 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ZORBTIVE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Emd Serono ZORBTIVE somatropin recombinant INJECTABLE;INJECTION 021597-004 Dec 1, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Emd Serono ZORBTIVE somatropin recombinant INJECTABLE;INJECTION 021597-004 Dec 1, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health
Merck
Boehringer Ingelheim
Daiichi Sankyo
Medtronic
Mallinckrodt
Healthtrust
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.